 |
Transgenic human alpha 1 antitrypsin |
|---|---|
| Trade Name | |
| Orphan Indication | Emphysema secondary to alpha 1 antitrypsin deficiency |
| USA Market Approval | USA |
| USA Designation Date | 1999-05-19 00:00:00 |
| Sponsor | PPL Therapeutics (Scotland) Limited;Roslin, Edinburgh, EH259PP Scotland; |
